Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors
-
Published:2022-12
Issue:
Volume:Volume 14
Page:3421-3435
-
ISSN:1179-1322
-
Container-title:Cancer Management and Research
-
language:en
-
Short-container-title:CMAR
Author:
Gaitonde Priyanka,
Chirikov Viktor,
Kelkar Sneha,
Liljas BengtORCID
Publisher
Informa UK Limited
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献